Department of Pharmacy Practice and Science
University of Kentucky
Director of Oncology and Infusion Pharmacy
Markey Cancer Center
UK Health Care
Thoracic Oncology Program
Swedish Cancer Institute
Associate Managing Editor
Senior Clinical Editor
Editorial Director, Hematology/Oncology
Senior Managing Editor
This program is intended for pharmacists, managed care professionals, and healthcare providers who care for patients with non-small-cell lung cancer.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008162-9999-18-084-H01-P
Type of Activity: Knowledge
Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 23, 2018, through April 22, 2019:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.
Download this PDF resource of expert recommendations on the optimal use of immune checkpoint inhibitors in patients with advanced NSCLC, including therapy selection and adverse event management.
In this downloadable slideset, Sandra Cuellar, PharmD, BCOP, reviews pharmacy perspectives in the assessment and management of adverse events associated with immune checkpoint therapy in the care of patients with stage III NSCLC.
In this downloadable slideset, Mark M. Awad, MD, PhD, juxtaposes historical data for concurrent CRT with new evidence for immune checkpoint therapy in the care of patients with stage III NSCLC.
In this downloadable slideset, Ali McBride PharmD, MS, BCOP, FAzPA, explores the underlying rationale for immune checkpoint inhibitor therapy in the care of patients with stage III NSCLC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.